These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3853525)

  • 21. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lysozyme levels in Crohn's disease and ulcerative colitis.
    Peeters TL; Vantrappen G; Geboes K
    Gut; 1976 Apr; 17(4):300-5. PubMed ID: 773792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Hylander E; Hansen NE; Karle H; Janrum S
    Scand J Gastroenterol; 1976; 11(2):213-7. PubMed ID: 1265442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
    Vucelić B; Krznarić Z; Sentić M; Milicić D; Korać B; Cvorisćec D; Stavljenić A
    Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR; Perrotto JL; Isselbacher KJ
    N Engl J Med; 1975 Feb; 292(8):395-7. PubMed ID: 1110725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can 99Tcm HMPAO leucocyte scintigraphy distinguish between Crohn's disease and ulcerative colitis?
    Li DJ; Freeman A; Miles KA; Wraight EP
    Br J Radiol; 1994 May; 67(797):472-7. PubMed ID: 8193894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cardiopulmonary bypass on circulating concentrations of leucocyte elastase and free radical activity.
    Hind CR; Griffin JF; Pack S; Latchman YE; Drake HF; Jones HM; Brostoff J; Dormandy TL; Treasures T
    Cardiovasc Res; 1988 Jan; 22(1):37-41. PubMed ID: 3048690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
    Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease.
    Arber N; Berliner S; Hallak A; Bujanover Y; Dotan I; Liberman E; Santo M; Moshkowitz M; Ratan J; Dotan G
    Gut; 1995 Jul; 37(1):77-80. PubMed ID: 7672686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
    Stallmach A; Langbein C; Atreya R; Bruns T; Dignass A; Ende K; Hampe J; Hartmann F; Neurath MF; Maul J; Preiss JC; Schmelz R; Siegmund B; Schulze H; Teich N; von Arnim U; Baumgart DC; Schmidt C
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1199-1212. PubMed ID: 27714831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiol methyltransferase activity in inflammatory bowel disease.
    Roediger WE; Babidge WJ
    Gut; 2000 Aug; 47(2):206-10. PubMed ID: 10896911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease.
    Stalnikowicz R; Goder K; Karmeli F; Fiocchi C; Rachmilewitz D
    Gut; 1985 Jun; 26(6):556-61. PubMed ID: 2408970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
    Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Berdowska I; Zielinski B; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2009 Jan; 15(1):93-9. PubMed ID: 18626964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.